FlatPress My FlatPress blog FlatPress Admin 2026 2026-10-10T16:39:36+00:00 Admin ~/ Blog - Closing the Succession Gap: How Interim Leadership Protects Family Businesses ~/?x=entry:entry260710-140913 2026-07-10T14:09:13+00:00 2026-07-10T14:09:13+00:00

When succession is not handled properly and on time in a family business, the stakes go far beyond filling a leadership role. Jobs, wealth, responsibility, and the company’s identity are all at risk. [Read More…]

 Blog - C-Level Interim Management: A Smart Response to the Leadership Shortage ~/?x=entry:entry260608-111947 2026-06-08T11:19:47+00:00 2026-06-08T11:19:47+00:00

Have you ever noticed how much a company slows down when a key leadership position stays vacant for months?
Decisions stall. [Read More…]

 Case Study - Turning Crisis into Growth: Sales Turnaround in MedTech ~/?x=entry:entry260608-094520 2026-06-08T09:45:20+00:00 2026-06-08T09:45:20+00:00

Core Elements of a Successful Turnaround.jpgIndustry: Medical Technology
Function: Sales and Country Manager
Topics: Reorganization, Restructuring, Turnaround
Revenue: €100 million at project start - €125 million at project end
Team Size: 180 team members

The Starting Point: A Crisis with Many Facets
My mission was clear: Getting a loss-making business unit back on the road to success. However, the challenges were complex. [Read More…]

 Case Study - People at the Center: Empowering Teams to Independence ~/?x=entry:entry260608-091928 2026-06-08T09:19:28+00:00 2026-06-08T09:19:28+00:00

Path to Profitability - Country Autonomy.jpg
Industry: Medical Technology (non-invasive ambulatory tumor therapy)
Function: General Management and Sales (DACH)
Topics: Organizational Structure and Processes, Building Business Units, Business Development, Consultative Selling, Talent Development & Leadership
Revenue: from €3 million to €9 million
Employees: from 2 to 20

Starting Point: A blank slate in Europe’s largest and most challenging market
When I took over responsibility for Germany, the company, a global MedTech pioneer with a newly approved device-based neuro-oncological therapy, had its European headquarters in Switzerland but no local structure in Germany at all. All activities had been managed remotely from the Swiss headquarters up to that point. [Read More…]